INVESTIGATIONAL NEW DRUGS
Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.
Journal Title
INVESTIGATIONAL NEW DRUGS
INVEST NEW DRUG
ISSN / eISSN
0167-6997 / 1573-0646
Aims and Scope
The development of new anticancer agents is one of the most rapidly changing aspects of cancer research. Investigational New Drugs provides a forum for the rapid dissemination of information on new anticancer agents. The papers published are of interest to the medical chemist, toxicologist, pharmacist, pharmacologist, biostatistician and clinical oncologist. Investigational New Drugs provides the fastest possible publication of new discoveries and results for the whole community of scientists developing anticancer agents.
Subject Area
PHARMACOLOGY & PHARMACY
ONCOLOGY
CiteScore
7.60
View Trend
CiteScore Ranking
| Category | Quartile | Rank |
|---|---|---|
| Medicine - Pharmacology (medical) | Q1 | #43/272 |
| Medicine - Oncology | Q1 | #88/404 |
| Medicine - Pharmacology | Q2 | #80/313 |
Web of Science Core Collection
| Science Citation Index Expanded (SCIE) | Social Sciences Citation Index (SSCI) |
|---|---|
| Indexed | - |
| Category (Journal Citation Reports 2024) | Quartile |
|---|---|
| ONCOLOGY | Q2 |
| PHARMACOLOGY & PHARMACY | Q2 |
H-index
80
Country/Area of Publication
UNITED STATES
Publisher
Springer US
Publication Frequency
Quarterly
Year Publication Started
1983
Annual Article Volume
87
Open Access
NO
Contact
SPRINGER, VAN GODEWIJCKSTRAAT 30, DORDRECHT, NETHERLANDS, 3311 GZ
Verified Reviews
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started